NUREXONE BIOLOGIC INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 57.87B | - | |||||
| 40.25B | ||||||
| 39.94B | ||||||
| 28.54B | ||||||
| 26.4B |
